Emmessar Biotech & Nutrition
EMMESSABSE

Emmessar Biotech & Nutrition

₹25.84-0.56 (2.12%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
24.11
Today’s high
26.33
52 week low
18.42
52 week high
42.90
Open price
26.33
Previous close
26.40
Live volume
286
Lower circuit
21.12
Upper circuit
31.68

Fundamentals

Market Cap
₹13Cr
ROE
5.37%
P/E Ratio(TTM)
30.34
EPS(TTM)
0.87
P/B Ratio
1.63
Dividend Yield
0.00%
Industry P/E
42.87
Book Value
16.24
Debt to Equity
0.00
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹0.56
-3.45%
Profit (Cr)
₹0.03
-75.00%
-2-1012
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-21%
3Y CAGR-33%
Profit growthValue
1Y (TTM)+143%
3Y CAGR-20%

About

Emmessar Biotech & Nutrition Ltd. operates in the global healthcare and nutritional products industry, adapting to growing consumer interest in holistic medicine. The company's distinct strategy is built around 'VedaCeuticals', a concept that fuses ancient Ayurveda with modern pharmaceuticals. This method involves programming food ingredients to serve as both body-building nutrition and as medicine for curing diseases. It actively manufactures CalmCream and also trades other brands like Cute-n-Comely, Magicream, and Muscle Flex Gel through a partner company. This dual focus on manufacturing and trading allows the company to serve a wide variety of healthcare needs and expand its market presence. EBNL has also made significant progress by developing a dedicated e-commerce platform to improve the sale and distribution of its healthcare products.;
CEO/MD
Mr. Srinivasa Raghavan Mathurakavi Ayyangar
Founded in
--
BSE symbol
524768

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
59.53%
Retail And Others
40.28%
Other Domestic Institutions
0.14%
Mutual Funds
0.05%
2026
12
May
Quarterly & Annual Result
Release date
11
Feb
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
7
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks